Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
Non-alcoholic fatty liver disease (NAFLD) constitutes the most common liver disease worldwide, and is frequently linked to the metabolic syndrome. The latter represents a clustering of related cardio-metabolic components, which are often observed in patients with NAFLD and increase the risk of cardi...
Enregistré dans:
Auteurs principaux: | Sue Shea, Christos Lionis, Chris Kite, Lou Atkinson, Surinderjeet S. Chaggar, Harpal S. Randeva, Ioannis Kyrou |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5860547aea9e4ee9a5effc8cee9f7d89 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Risk of Non-Alcoholic Fatty Liver Disease in Xanthelasma Palpebrarum
par: Chen HW, et autres
Publié: (2021) -
Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
par: Daniela Maria Tanase, et autres
Publié: (2021) -
Loss of progesterone receptor membrane component 1 promotes hepatic steatosis via the induced de novo lipogenesis
par: Sang R. Lee, et autres
Publié: (2018) -
Foresight regarding drug candidates acting on the succinate–GPR91 signalling pathway for non-alcoholic steatohepatitis (NASH) treatment
par: Chengyuan Liang, et autres
Publié: (2021) -
Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases
par: Rocío Gallego-Durán, et autres
Publié: (2021)